BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217109. A total of 10 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,480 | +3.4% | 1,000,000 | 0.0% | 1.08% | +142.7% |
| Q4 2022 | $10,140 | -99.8% | 1,000,000 | +100.0% | 0.44% | +30.7% |
| Q3 2022 | $5,020,000 | -49.9% | 500,000 | -50.0% | 0.34% | +10.4% |
| Q2 2022 | $10,020,000 | +100.8% | 1,000,000 | +100.0% | 0.31% | +3.0% |
| Q1 2022 | $4,990,000 | -0.2% | 500,000 | 0.0% | 0.30% | -3.6% |
| Q4 2021 | $5,000,000 | – | 500,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CLEAR STREET LLC | 19,249 | $209 | 0.00% |
| UBS Group AG | 50 | $542 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |